Phase III Clinical Trial of Telitacicept Injection in the Treatment of Patients With Connective Tissue Disease-related Interstitial Lung Disease
Clinical trial NCT07495033 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07495033
- Sponsor
- RemeGen Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2029-05-31
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.